Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Merick Kirshner

Thoracic Surgery (Cardiothoracic Vascular Surgery) Phoenix, AZ Medical Doctor

NPI 1831183870 CMS profile 355257

2777 E Camelback Rd Ste 200, Phoenix, AZ 85016

Open in the dashboard

General payments

$108,553

397 records reported · program years 2019–2025

Research payments

$5,631

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$754,228 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Merick Kirshner of Phoenix, AZ is reported in the CMS Open Payments database as having received $108,553 across 397 general payments and $5,631 in research payments paid to them. Separately, studies naming them as principal investigator received $754,228 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,609 43
2024 General $3,458 48
2023 General $10,766 39
2022 General $14,148 59
2022 Research $5,631 1
2021 General $9,321 49
2020 General $24,370 50
2019 General $44,881 109

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Merick Kirshner
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Merick Kirshner were reported at $1,609. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Merick Kirshner Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $44,881 $886 $178–$3,167 $163
2020 $24,370 $341 $108–$1,605 $114
2021 $9,321 $453 $125–$1,886 $132
2022 $14,148 $695 $180–$2,566 $149
2023 $10,766 $745 $205–$2,662 $160
2024 $3,458 $799 $214–$2,967 $164
2025 $1,609 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $64,258 106 payments
  2. Medtronic, Inc. $33,566 109 payments
  3. Edwards Lifesciences Corporation $3,761 68 payments
  4. Abbott Laboratories $3,344 40 payments
  5. Atricure, Inc. $1,089 32 payments
  6. Abiomed $793 10 payments
  7. Bolton Medical Inc $406 4 payments
  8. Zimmer Biomet Holdings, Inc. $361 7 payments
  9. CVRx, Inc. $355 3 payments
  10. Boston Scientific Corporation $222 3 payments
  11. Other $399 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $88,200 40 payments
  2. Food and Beverage $13,857 325 payments
  3. Travel and Lodging $6,472 31 payments
  4. Education $25 1 payment
Products named General payments · program years 2019–2025
  1. CoreValve Evolut Transcatheter Valve Systems $61,801 74 payments
  2. COREVALVE EVOLUT R $21,121 35 payments
  3. CoreValve Evolut Transcatheter Valve Systems $8,708 32 payments
  4. Mitra Clip system $2,220 13 payments
  5. INSPIRIS RESILIA aortic valve Pericardial Heart Valves $1,448 8 payments
  6. SYNERGY ABLATION SYSTEM $952 26 payments
  7. Carpentier-Edwards Physio II Annuloplasty Ring $685 11 payments
  8. SAPIEN 3 Ultra RESILIA $673 25 payments
  9. Impella $610 8 payments
  10. INSPIRIS RESILIA AORTIC VALVE Pericardial Heart Valves $390 5 payments
  11. Other $5,563 145 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $5,631 1 payment

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$207,457

Medicare's payments for the services billed

Medicare patients

278

Average age 76

Services billed

807

93 women, 185 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 71%
Atrial fibrillation 55%
Arthritis 54%
Diabetes 50%
Chronic kidney disease 49%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

398 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record